AstraZeneca COVID-19 Vaccine 76% Effective In Updated US Trial Results
PUBLISHED ON: March 25, 2021 | Duration: 6 min, 14 sec
AstraZeneca said on Thursday its COVID-19 vaccine was 76% effective at preventing symptomatic illness, citing a new analysis of up-to-date results for its major US trial.
